1. 20240924 KyungDong Pharm Korea University Ansan Hospital agreement ceremony (1).jpg

 

KyungDong Pharm signed an agreement with Korea University Ansan Hospital for academic exchange and joint research. The signing ceremony took place on September 24 in the Libertas Lounge on the sixth floor of the hospital’s Future Medicine Building, attended by CEO Kim Kyung-hoon, Hospital Director Kwon Soon-young and other representatives. Under the agreement, the two organizations will collaborate on academic and interdisciplinary research. Areas of cooperation include translational and clinical research projects, technical collaboration and joint research, researcher exchanges to develop interdisciplinary expertise, expanded technology development, and networks for R&D and technology commercialization. Director Kwon said, “As university hospitals compete intensely to advance research, Korea University Ansan Hospital is making substantial efforts, including expanding research facilities under its medium- and long-term master plan. We hope this agreement will help us build distinctive capabilities in research, technology development, talent development and commercialization.” CEO Kim added, “The hospital’s research division has highly specialized researchers and infrastructure in areas of new drug development that interest KyungDong Pharm, including its rare disease and integrated healthcare programs. We expect the two organizations to create synergies by developing new projects in areas of mutual interest.”